Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

In silico studies-assisted design, synthesis, and discovery of biologically active isatin derivatives

Mohd Imran , Abida Ash Mohd, Naira Nayeem, Saleh Ibrahim Alaqel

Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia;

For correspondence:- Mohd Imran Email: mohammad.Baks@nbu.edu.sa Tel:+966599577945

Accepted: 25 May 2023 Published: 30 June 2023

Citation: Imran M, Mohd AA, Nayeem N, Alaqel SI. In silico studies-assisted design, synthesis, and discovery of biologically active isatin derivatives. Trop J Pharm Res 2023; 22(6):1263-1269 doi: 10.4314/tjpr.v22i6.16

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To design isatin-based compounds, carry out in silico studies, and identify the biologically active isatin derivatives.

Methods: Fourteen isatin-based compounds (A to N) were designed using ChemDraw. In addition, in silico studies (molecular docking, prediction of drug likeliness, gastrointestinal absorption, log P, and toxicity) of the designed compounds were compared to ciprofloxacin. Based on the results of the in silico studies, three compounds (G, H, and L) were selected for synthesis, and the chemical structures of G, H, and L were elucidated via spectral analysis. The antimicrobial activity and DNA gyrase inhibitory activity of G, H, and L were evaluated and compared to those of ciprofloxacin.

Results: The docking scores of compounds G, H, and L (-5.90, -5.72, and -5.98 kcal/mol, respectively) were comparatively better than that of ciprofloxacin (-5.41 kcal/mol). In silico studies data also revealed the non-hepatotoxic nature, drug-likeliness properties, and good gastrointestinal absorption for G, H, L, and ciprofloxacin. The in vitro antimicrobial activity (p < 0.05) and DNA gyrase inhibitory activity of G (102.33 %, p < 0.05), H (104.43 %, p < 0.05), and L (106.77 %, p < 0.05) were better than those of ciprofloxacin (100.0 %, p < 0.05).

Conclusion: Compounds G, H, and L are promising DNA gyrase inhibitors. These compounds should be explored further to determine their broad-spectrum antimicrobial potency, safety, and efficacy.

Keywords: Isatin, Molecular docking, Synthesis, Antimicrobial activity, DNA gyrase inhibitor